Literature DB >> 30322846

Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives.

Laura Galian-Gay1, Amelia Carro Hevia1, Gisela Teixido-Turà1, José Rodríguez Palomares1, Laura Gutiérrez-Moreno1, Giuliana Maldonado1, María Teresa Gonzàlez-Alujas1, Augusto Sao-Aviles1, Pastora Gallego2, Francisco Calvo-Iglesias3, Javier Bermejo4, Juan Robledo-Carmona5, Violeta Sánchez6, Daniel Saura7, Teresa Sevilla8, Sergio Burillo-Sanz9, Andrea Guala1, David Garcia-Dorado1, Arturo Evangelista1.   

Abstract

OBJECTIVE: Bicuspid aortic valve (BAV) is the most common congenital heart disease. This study aimed to determine the prevalence rate of BAV in first-degree relatives (FDR) and the inheritance pattern according to different morphotypes and aortic dilation.
METHODS: BAV probands were consecutively studied at eight tertiary referral centres. After sequential screening, FDR were included in the study. The BAV morphotype, aortic dilation and aortic phenotype were assessed by transthoracic echocardiography.
RESULTS: Seven hundred and twenty-four FDR of 256 BAV probands agreed to undergo family screening. The prevalence of BAV was 6.4% in FDR (9.2% in men, 3.5% in women, p=0.002). Aortic dilation was diagnosed in 9.6% of FRD with tricuspid aortic valves (TAV), with a root phenotype in 2.7% and tubular in 6.9% and more frequently in the presence of arterial hypertension (OR 4.48; CI 95% 2.51 to 7.99; p=0.0001) and valvular regurgitation (OR 5.87, CI 95% 1.37 to 25.16; p=0.025). The heritability (h2 ) of BAV was highly significant (0.47; p=0.002); however, no concordance was observed among valve morphotypes. Aortic dilation heritability was not significant.
CONCLUSIONS: The BAV prevalence rate in FDR was low (6.4%) but aortic dilation was observed in 9.6% of FDR with TAV. The heritability of BAV was high without concordance in valve morphotypes, and aortic dilation heritability was not observed. Patients with BAV should be made aware of its familial pattern. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  aortic and arterial disease; bicuspid aortic valve; clinical genetics; echocardiography

Mesh:

Year:  2018        PMID: 30322846     DOI: 10.1136/heartjnl-2018-313802

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

Review 1.  Genetics in bicuspid aortic valve disease: Where are we?

Authors:  Katia Bravo-Jaimes; Siddharth K Prakash
Journal:  Prog Cardiovasc Dis       Date:  2020-06-27       Impact factor: 8.194

2.  Leaflet fusion length is associated with aortic dilation and flow alterations in non-dysfunctional bicuspid aortic valve.

Authors:  Andrea Guala; Arturo Evangelista; Gisela Teixido-Tura; Lucia La Mura; Lydia Dux-Santoy; Aroa Ruiz-Muñoz; Filipa Valente; Laura Galian-Gay; Laura Gutiérrez; Teresa González-Alujas; Ilaria Dentamaro; Kevin M Johnson; Oliver Wieben; Augusto Sao Avilés; Ignacio Ferreira-Gonzalez; Jose F Rodríguez-Palomares
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

Review 3.  Valvular Heart Disease Epidemiology.

Authors:  John Sukumar Aluru; Adam Barsouk; Kalyan Saginala; Prashanth Rawla; Alexander Barsouk
Journal:  Med Sci (Basel)       Date:  2022-06-15

4.  Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions.

Authors:  Radoslaw Marek Debiec; Stephen E Hamby; Peter D Jones; Kassem Safwan; Michael Sosin; Simon Lee Hetherington; David Sprigings; David Sharman; Kelvin Lee; Pegah Salahshouri; Nigel Wheeldon; Andrew Chukwuemeka; Vasiliki Boutziouka; Mohamed Elamin; Sue Coolman; Manish Asiani; Shireen Kharodia; Gregory J Skinner; Nilesh J Samani; Tom R Webb; Aidan P Bolger
Journal:  Heart       Date:  2022-06-24       Impact factor: 7.365

5.  Applications of a Specialty Bicuspid Aortic Valve Program: Clinical Continuity and Translational Collaboration.

Authors:  Erin E Crawford; Patrick M McCarthy; S Chris Malaisrie; Jyothy J Puthumana; Joshua D Robinson; Michael Markl; Menghan Liu; Adin-Cristian Andrei; David G Guzzardi; Jane Kruse; Paul W M Fedak
Journal:  J Clin Med       Date:  2020-05-05       Impact factor: 4.241

6.  A de novo pathogenic BMP2 variant-related phenotype with the novel finding of bicuspid aortic valve.

Authors:  Neha Ahluwalia; Bruce D Gelb
Journal:  Am J Med Genet A       Date:  2020-11-27       Impact factor: 2.802

Review 7.  Update in Biomolecular and Genetic Bases of Bicuspid Aortopathy.

Authors:  Alejandro Junco-Vicente; Álvaro Del Río-García; María Martín; Isabel Rodríguez
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 8.  Aortic Dilatation in Patients With Bicuspid Aortic Valve.

Authors:  Jing Wang; Wenhui Deng; Qing Lv; Yuman Li; Tianshu Liu; Mingxing Xie
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

Review 9.  Unraveling Bicuspid Aortic Valve Enigmas by Multimodality Imaging: Clinical Implications.

Authors:  Arturo Evangelista Masip; Laura Galian-Gay; Andrea Guala; Angela Lopez-Sainz; Gisela Teixido-Turà; Aroa Ruiz Muñoz; Filipa Valente; Laura Gutierrez; Ruben Fernandez-Galera; Guillem Casas; Alejandro Panaro; Alba Marigliano; Marina Huguet; Teresa González-Alujas; Jose Rodriguez-Palomares
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

Review 10.  Global epidemiology of valvular heart disease.

Authors:  Sean Coffey; Ross Roberts-Thomson; Alex Brown; Jonathan Carapetis; Mao Chen; Maurice Enriquez-Sarano; Liesl Zühlke; Bernard D Prendergast
Journal:  Nat Rev Cardiol       Date:  2021-06-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.